Valvular Heart Disease News and Research

RSS

Northwestern Medicine and Eko join hands to improve heart disease screening with AI technology

Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of artificial intelligence for cardiac screening in a new study of Eko's cardiac monitoring platform.

8 Mar 2019

Researchers shed light on molecular mechanisms of heart valvular disease

About three per cent of the world's population is affected by valvular heart diseases. It is also the most common cause of heart surgery, as no drug-based treatment is available.

20 Nov 2018

Using speckle-tracking echocardiography to evaluate cardiac diseases

In the current issue of Cardiovascular Innovations and Applications (Volume3, Number 2, 2018, pp. 237-250(14); DOI: https://doi.org/10.15212/CVIA.2017.0040 Randy R. Jeffrey, Robert F. Hamburger, Janelle Gooden-Ebanks and John W. Petersen from the Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL, USA consider impaired longitudinal strain as a common deficit in various cardiac diseases.

11 Sep 2018

New study finds that pregnancy is safe for most women with heart disease

Is it safe for women with heart disease to become pregnant? Usually, according to ten-year results from the ROPAC registry reported in a late breaking science session today at ESC Congress 2018.

28 Aug 2018

Study demonstrates cardiovascular safety of weight loss drug

A weight loss drug does not increase cardiovascular events, according to late breaking results from the CAMELLIA-TIMI 61 trial presented today in a Hot Line Session at ESC Congress and published in the New England Journal of Medicine.

27 Aug 2018

Research provides drug developers with much needed insight into serotonin receptor

Serotonin, known as the "happiness" neurotransmitter, is a chemical found in the body responsible for feelings of well-being. But serotonin isn't the only chemical that binds to the 13 serotonin receptors found on the surface of cells. Far from it. Many approved drugs also bind to serotonin receptors.

21 Aug 2018

ESC recommendations on management of patients with peripheral arterial diseases published

European Society of Cardiology Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular Surgery (ESVS), are published online today in European Heart Journal, European Journal of Vascular and Endovascular Surgery, and the ESC website.

26 Aug 2017

ACC launches educational forums to address growing burden of valvular heart disease in China

The American College of Cardiology, working with prominent hospitals in central and eastern China, is launching a series of educational forums for physicians on valvular heart disease prevention, diagnosis and management.

25 Jul 2017

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Men seem to have worse chemotherapy-induced cardiomyopathy than women despite receiving similar cancer treatments, according to research presented today at EuroCMR 2017.

25 May 2017

EuroPCR 2017 brings together interventional cardiologists to celebrate success and develop innovations

EuroPCR 2017, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions, pushed back barriers in bringing together young and established interventional cardiologists to learn from past successes, build understanding and experience of new percutaneous interventional approaches, and develop innovations for the future at this year's course held from 16 to 19 May 2017 at the Palais des Congrès in Paris, France.

24 May 2017

CRF to release new international journal focusing on diagnosis, treatment of structural heart disease

The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.

11 Nov 2016

Experts to discuss use of holograms and 3D printing at EuroEcho-Imaging 2016

EuroEcho-Imaging 2016 brings advanced techniques to the bedside with international experts set to discuss the use of holograms and 3D printing to guide interventions.

7 Nov 2016

Simplified approach to TAVI holds potential to save lives of many patients with rheumatic heart disease

A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with rheumatic heart disease who need the procedure each year. The research is being presented at the SA Heart Congress 2016

9 Sep 2016

PinnacleHealth replaces aortic valve in two patients using minimally invasive surgery

This week, PinnacleHealth became the first hospital in the country to implant the EDWARDS INTUITY Elite valve, a rapid deployment device for surgical aortic valve replacement, after U.S. Food and Drug Administration approval.

26 Aug 2016

Unidentified valvular heart disease very common in elderly

Over half of community-living elderly people are likely to have valvular heart disease, show findings of OxVALVE-PCS.

30 Jun 2016

Unseen health risks of aortic stenosis: an interview with Dr Shelley Rahman Haley

Aortic stenosis means narrowing of the aortic valve, which is the out flow valve from the left ventricle, the pumping chamber of the heart. This is the valve which opens to allow blood to flood out of the heart and all-round the body.

22 Jun 2016

Long-term Warfarin use may increase dementia rates in AF patients

A new study of more than 10,000 patients treated long term with the blood thinner, Warfarin, reveals higher rates of dementia for patients with atrial fibrillation versus non-AF patients

5 May 2016

UAB researchers focus on five key areas to improve care of CVD patients

According to the Centers for Disease Control and Prevention, approximately 610,000 people die of heart disease in the United States every year — that's one in every four deaths. The impact of cardiovascular diseases is quite large.

28 Feb 2016

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.

16 Oct 2015

Training session can improve cardiologists’ ability to detect basic and advanced murmurs

Cardiologists failed to identify more than half of basic and about 35 percent of advanced pre-recorded murmurs, but skills improved after a 90 minute training session, according to research presented today at the European Society of Cardiology Congress 2015.

1 Sep 2015